Director, Global Market Access
Core
Lead global pricing and market access strategy for Alnylam's Rare Disease portfolio and selected pipeline assets, ensuring consistent access approaches across current and future products.
Role type
Director, Global Market Access (Strategy & Pricing)
Builds
Strategic access plans, payer value stories, and pricing strategies for specialty rare disease products.
Domain
Biopharmaceuticals / Rare Diseases / Market Access
Deliverable
production ML models | product features | dashboards & analysis | research | client delivery | infrastructure | physical/clinical work
Required skills
Strategic planning, payer segmentation, contract negotiation, pricing strategy, cross-functional leadership, data-driven decision making, competitive landscape analysis, evidence generation guidance, stakeholder management, project prioritization
Preferred skills
MBA, MPH, PharmD, Health Economics/Outcomes Research background, rare disease domain expertise
Technologies
Global Pricing System (GPS), health economics modeling tools, market access analytics platforms
Responsibilities
Develop strategic access plans for in-line brands, new assets, and pipeline products; communicate access strategies to internal business partners; manage the Global Pricing System including quarterly updates and reporting; champion priority access initiatives; collaborate with regional counterparts to share learnings; serve as single-point-of-contact for pricing strategy; develop payer value stories supported by clinical and health economics data; anticipate competitor moves and develop innovative market access tactics.
Seniority
Director, strategic leadership with hands-on execution
